Home / Stocks / ANTX

ANTX insider trading

AN2 Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
9
Bought · 24 mo
$516k
Buys · last 90 days
1 · $12k
Most recent buy
2026-09-02

Cluster buy detected

3 insiders bought ANTX within a short window (2024-11-18→2024-12-06), $483k in total — cluster score 53/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-09-02FitzPatrick Margaret M
Director
Bought2,098$5.53$12k
2025-06-03Easom Eric
Chief Executive Officer
Bought10,000$1.07$11k
2025-05-30Leonard Braden Michael
10% owner
Sold2,000,000$1.16$2.3M
2025-05-29FitzPatrick Margaret M
Director
Bought8,610$1.18$10k
2024-12-10Readnour Robin Shanecluster
Director
Bought60,000$1.45$87k
2024-11-27Readnour Robin Shanecluster
Director
Bought75,000$1.41$106k
2024-11-27Zakrzewski Joseph Scluster
Director
Bought2,000$1.40$3k
2024-11-21Readnour Robin Shanecluster
Director
Bought200,000$1.06$213k
2024-11-20Zakrzewski Joseph Scluster
Director
Bought25,000$1.00$25k
2024-11-18Easom Ericcluster
Chief Executive Officer
Bought50,000$1.00$50k

Most active insider buyers

InsiderRoleBuysTotal bought
Readnour Robin ShaneDirector3$406k
Easom EricChief Executive Officer2$61k
Zakrzewski Joseph SDirector2$28k
FitzPatrick Margaret MDirector2$22k

See ANTX on the chart

Every insider buy and sell for ANTX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.